NCT03602911View on ClinicalTrials.gov

A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

The isotope 68Ga, NETSPOT and 18F-FDG-PET/CT

All patients will undergo 18F-FDG-PET/CT per established protocol. Following 18F-FDG-PET/CT, the patient will undergo NETSPOT imaging

Trial Locations (1)

26501

West Virginia University Medicine, Morgantown

All Listed Sponsors
lead

West Virginia University

OTHER

NCT03602911 - A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients | Biotech Hunter | Biotech Hunter